While nutritional, psychological, and physical approaches to health that can be used along with conventional MS treatments to help you manage your symptoms, alternative and complementary therapies ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Age is a major modifier of inflammatory CSF signatures in MS. This finding identifies novel biomarker candidates and potential therapeutic targets.